Debio 1143-201 Dose-finding and Efficacy Phase I/II Trial

NCT02022098 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

144

Enrollment

INDUSTRY

Sponsor class

Conditions

Squamous Cell Carcinoma of the Head and Neck

Interventions

DRUG: Cisplatin
RADIATION: Radiotherapy
DRUG: Debio 1143
DRUG: Placebo

Sponsor

Debiopharm International SA